Advisory Committee on Organ Transplantation; Notice of Meeting, 10494 [2015-03929]

Download as PDF 10494 Federal Register / Vol. 80, No. 38 / Thursday, February 26, 2015 / Notices Monday through Friday, and will be posted to the docket at http:// www.regulations.gov. Transcripts: As soon as a transcript is available, FDA will post it at http:// wwww.fda.gov/NewsEvents/ MeetingsConferencesWorkshops/ ucm433552.htm. Dated: February 20, 2015. Leslie Kux, Associate Commissioner for Policy. [FR Doc. 2015–03974 Filed 2–25–15; 8:45 am] BILLING CODE 4164–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration rmajette on DSK2VPTVN1PROD with NOTICES Advisory Committee on Organ Transplantation; Notice of Meeting In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), notice is hereby given of the following meeting: Name: Advisory Committee on Organ Transplantation (ACOT). Date and Time: March 12, from 8:30 a.m. to 4:30 p.m. Eastern Standard Time. March 13, from 8:30 a.m. to 12:30 p.m. Eastern Standard Time. Place: Health Resources and Services Administration, 5600 Fishers Lane, Room 05W11, Rockville, MD 20857. Status: The meeting will be open to the public. Purpose: Under the authority of 42 U.S.C. Section 217a, Section 222 of the Public Health Service Act, as amended, and 42 CFR 121.12 (2000), ACOT was established to assist the Secretary in enhancing organ donation, ensuring that the system of organ transplantation is grounded in the best available medical science, and assuring the public that the system is as effective and equitable as possible, thereby increasing public confidence in the integrity and effectiveness of the transplantation system. ACOT is composed of up to 25 members including the Chair. Members serve as Special Government Employees and have diverse backgrounds in fields such as organ donation, health care public policy, transplantation medicine and surgery, critical care medicine, and other medical specialties involved in the identification and referral of donors, non-physician transplant professions, nursing, epidemiology, immunology, law and bioethics, behavioral sciences, economics and statistics, as well as representatives of transplant candidates, transplant recipients, organ donors, and family members. VerDate Sep<11>2014 15:27 Feb 25, 2015 Jkt 235001 Agenda: The Committee will hear presentations, including those on the following topics: Kidney Paired Donation; Vascularized Composite Allografts; Donor Management Research; Living Donation; and the Affordable Care Act and Transplantation. Agenda items are subject to change as priorities indicate. After Committee discussions, members of the public will have an opportunity to comment. Because of the Committee’s full agenda and timeframe in which to cover the agenda topics, public comment will be limited. All public comments will be included in the record of the ACOT meeting. Meeting summary notes will be posted on the Department’s organ donation Web site at http://www.organdonor.gov/ legislation/advisory.html#meetings. The draft meeting agenda will be posted on www.blsmeetings.net/ACOT. Those participating on this meeting should pre-register by visiting www.blsmeetings.net/ACOT. The deadline to pre-register for this meeting is Wednesday, March 11, 2015. Registration will be confirmed on site. For all logistical questions and concerns, please contact Anita Allen, Seamon Corporation at 301–658–3442 or send an email to aallen@ seamoncorporation.com. Public Comment: It is preferred that persons interested in providing an oral presentation email a written request, along with a copy of their presentation, to Patricia Stroup, MBA, MPA, Executive Secretary, Healthcare Systems Bureau, Health Resources and Services Administration, at pstroup@hrsa.gov. Requests should contain the name, address, telephone number, email address, and any business or professional affiliation of the person desiring to make an oral presentation. Groups having similar interests are requested to combine their comments and present them through a single representative. The allocation of time may be adjusted to accommodate the level of expressed interest. Persons who do not file an advance request for a presentation, but desire to make an oral statement, may request it during the public comment period. Public participation and ability to comment will be limited to time as it permits. FOR FURTHER INFORMATION CONTACT: Patricia Stroup, MBA, MPA, Executive Secretary, Healthcare Systems Bureau, Health Resources and Services Administration, 5600 Fishers Lane, PO 00000 Frm 00040 Fmt 4703 Sfmt 4703 Room 17W65, Rockville, MD 20857; telephone (301) 443–1127. Jackie Painter, Director, Division of the Executive Secretariat. [FR Doc. 2015–03929 Filed 2–25–15; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Submission for OMB Review; Emergency Clearance Request Human Influenza Surveillance of Health Care Centers in the United States and Taiwan In accordance with Section 3507(j) of the Paperwork Reduction Act of 1995, the National Institute of Allergy and Infectious Diseases (NIAID), the National Institutes of Health (NIH), has submitted to the Office of Management and Budget (OMB) a request for emergency review and processing of this information collection by March 7, 2015. NIAID is requesting emergency processing of this information collection, pursuant to 5 CFR 1320.13, because NIAID cannot reasonably comply with the normal clearance procedures which would cause a delay and likely prevent or substantially disrupt the collection of information. A delay in starting the information collection would hinder the agency in accomplishing its mission to the detriment of the public good. Public harm could result through the loss of critically needed information to understand the causes of severity of influenza and associated morbidity and mortality during the Northern hemisphere 2014–15 influenza season. The National Institutes of Health may not conduct or sponsor, and the respondent is not required to respond to, an information collection that has been extended, revised, or implemented on or after October 1, 1995, unless it displays a currently valid OMB control number. Written comments and/or suggestions from the public and affected agencies are invited on one or more of the following points: (1) Whether the proposed collection of information is necessary for the proper performance of the function of the agency, including whether the information will have practical utility; (2) The accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (3) Ways to enhance the quality, utility, and clarity of the information to be collected; and (4) Ways to minimize the SUMMARY: E:\FR\FM\26FEN1.SGM 26FEN1

Agencies

[Federal Register Volume 80, Number 38 (Thursday, February 26, 2015)]
[Notices]
[Page 10494]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-03929]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Advisory Committee on Organ Transplantation; Notice of Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), notice is hereby given of the following 
meeting:
    Name: Advisory Committee on Organ Transplantation (ACOT).
    Date and Time: March 12, from 8:30 a.m. to 4:30 p.m. Eastern 
Standard Time. March 13, from 8:30 a.m. to 12:30 p.m. Eastern Standard 
Time.
    Place: Health Resources and Services Administration, 5600 Fishers 
Lane, Room 05W11, Rockville, MD 20857.
    Status: The meeting will be open to the public.
    Purpose: Under the authority of 42 U.S.C. Section 217a, Section 222 
of the Public Health Service Act, as amended, and 42 CFR 121.12 (2000), 
ACOT was established to assist the Secretary in enhancing organ 
donation, ensuring that the system of organ transplantation is grounded 
in the best available medical science, and assuring the public that the 
system is as effective and equitable as possible, thereby increasing 
public confidence in the integrity and effectiveness of the 
transplantation system. ACOT is composed of up to 25 members including 
the Chair. Members serve as Special Government Employees and have 
diverse backgrounds in fields such as organ donation, health care 
public policy, transplantation medicine and surgery, critical care 
medicine, and other medical specialties involved in the identification 
and referral of donors, non-physician transplant professions, nursing, 
epidemiology, immunology, law and bioethics, behavioral sciences, 
economics and statistics, as well as representatives of transplant 
candidates, transplant recipients, organ donors, and family members.
    Agenda: The Committee will hear presentations, including those on 
the following topics: Kidney Paired Donation; Vascularized Composite 
Allografts; Donor Management Research; Living Donation; and the 
Affordable Care Act and Transplantation. Agenda items are subject to 
change as priorities indicate.
    After Committee discussions, members of the public will have an 
opportunity to comment. Because of the Committee's full agenda and 
timeframe in which to cover the agenda topics, public comment will be 
limited. All public comments will be included in the record of the ACOT 
meeting. Meeting summary notes will be posted on the Department's organ 
donation Web site at http://www.organdonor.gov/legislation/advisory.html#meetings.
    The draft meeting agenda will be posted on www.blsmeetings.net/ACOT. Those participating on this meeting should pre-register by 
visiting www.blsmeetings.net/ACOT. The deadline to pre-register for 
this meeting is Wednesday, March 11, 2015. Registration will be 
confirmed on site. For all logistical questions and concerns, please 
contact Anita Allen, Seamon Corporation at 301-658-3442 or send an 
email to aallen@seamoncorporation.com.
    Public Comment: It is preferred that persons interested in 
providing an oral presentation email a written request, along with a 
copy of their presentation, to Patricia Stroup, MBA, MPA, Executive 
Secretary, Healthcare Systems Bureau, Health Resources and Services 
Administration, at pstroup@hrsa.gov. Requests should contain the name, 
address, telephone number, email address, and any business or 
professional affiliation of the person desiring to make an oral 
presentation. Groups having similar interests are requested to combine 
their comments and present them through a single representative.
    The allocation of time may be adjusted to accommodate the level of 
expressed interest. Persons who do not file an advance request for a 
presentation, but desire to make an oral statement, may request it 
during the public comment period. Public participation and ability to 
comment will be limited to time as it permits. FOR FURTHER INFORMATION 
CONTACT: Patricia Stroup, MBA, MPA, Executive Secretary, Healthcare 
Systems Bureau, Health Resources and Services Administration, 5600 
Fishers Lane, Room 17W65, Rockville, MD 20857; telephone (301) 443-
1127.

Jackie Painter,
Director, Division of the Executive Secretariat.
[FR Doc. 2015-03929 Filed 2-25-15; 8:45 am]
BILLING CODE 4165-15-P